alleyoop Posted August 17, 2010 Share Posted August 17, 2010 The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2010.01691.x/abstract Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.